Table 2. Effect of Inhibitors on the... | American Society of Hematology

Table 2.

Effect of Inhibitors on the Number of Macrophages Taking up Apoptotic PMN (%)

	Control	RGDS (1 mmol/L)	RGES (1 mmol/L)	Phospho-L Serine (1 mmol/L)
Control	32 ± 2.4	9.2^* ± 1	30.6 ± 2	28.2 ± 2.2
IFN-TNF (20 U/mL, 10 ng/mL)	18.0 ± 2.3	7.9^* ± 1.5	17.9 ± 4.8	16.3 ± 3.2
TNF (10 ng/mL)	42.6 ± 2.4	15^* ± 1.8	39.7 ± 3.1	43 ± 3
TGF (7.5 ng/mL)	28 ± 4.2	14.1^† ± 2.1	27.5 ± 3.3	24.8 ± 3
IL-4 (5 μL/mL)	12.6 ± 2.2	5.7^† ± 1.9	13.5 ± 1	12.1 ± 1.3

	Control	RGDS (1 mmol/L)	RGES (1 mmol/L)	Phospho-L Serine (1 mmol/L)
Control	32 ± 2.4	9.2^* ± 1	30.6 ± 2	28.2 ± 2.2
IFN-TNF (20 U/mL, 10 ng/mL)	18.0 ± 2.3	7.9^* ± 1.5	17.9 ± 4.8	16.3 ± 3.2
TNF (10 ng/mL)	42.6 ± 2.4	15^* ± 1.8	39.7 ± 3.1	43 ± 3
TGF (7.5 ng/mL)	28 ± 4.2	14.1^† ± 2.1	27.5 ± 3.3	24.8 ± 3
IL-4 (5 μL/mL)	12.6 ± 2.2	5.7^† ± 1.9	13.5 ± 1	12.1 ± 1.3

This table shows the effect of inhibitors on recognition of apoptotic PMNs by control and cytokine-stimulated BMDM.

P < .01 relative to controls.

P < .05 relative to controls.